Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Mitrou

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1993
Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemiaL Bergmann, K Fenchel, B Jahn, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1994
In vivo regulation of transforming growth factor beta 1 transcription by immunotherapy: interleukin-2 impairs interferon-alpha-stimulated increase in steady-state mRNA levels of transforming growth factor beta 1B Jahn, J Brieger, K Fenchel, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1992
Rapid cytokine release in cancer patients treated with interleukin-2E Weidmann, L Bergmann, J Stock, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1990
Influence of various cytokines on the induction of lymphokine-activated killer cellsL Bergmann, E Weidmann, B Bungert, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
High-dose adriamycin (ADM) and cis-platinum (DDP) in advanced soft-tissue sarcomas and invasive thymomas. A pilot studyT H Klippstein, P S Mitrou, K J Kochendörfer, et al.
Deutsche Medizinische Wochenschrift (1946)|June 28, 1974
[Splenectomy in Hodgkin's disease (author's transl)]M Fischer, P S Mitrou, K Hübner, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Recombinant human granulocyte-macrophage colony-stimulating factor after combined chemotherapy in high-grade non-Hodgkin's lymphoma--a randomised pilot studyL Bergmann, T Karakas, A Knuth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCRJ Brieger, E Weidmann, U Maurer, et al.
Praxis Und Klinik Der Pneumologie|May 1, 1977
[Pulmonary manifestations of collagen diseases and necrotizing angiitis (author's transl)]J Meier-Sydow, M Amthor, P S Mitrou, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Impaired T- and B-cell functions in patients with Hodgkin's disease. Reduced mitogenic responsibility and Il-2 production is not caused by defective CD4+-cellsL Bergmann, P S Mitrou, M Demmer-Dieckmann, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1993
Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemiaL Bergmann, K Fenchel, B Jahn, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1994
In vivo regulation of transforming growth factor beta 1 transcription by immunotherapy: interleukin-2 impairs interferon-alpha-stimulated increase in steady-state mRNA levels of transforming growth factor beta 1B Jahn, J Brieger, K Fenchel, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1992
Rapid cytokine release in cancer patients treated with interleukin-2E Weidmann, L Bergmann, J Stock, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1990
Influence of various cytokines on the induction of lymphokine-activated killer cellsL Bergmann, E Weidmann, B Bungert, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
High-dose adriamycin (ADM) and cis-platinum (DDP) in advanced soft-tissue sarcomas and invasive thymomas. A pilot studyT H Klippstein, P S Mitrou, K J Kochendörfer, et al.
Deutsche Medizinische Wochenschrift (1946)|June 28, 1974
[Splenectomy in Hodgkin's disease (author's transl)]M Fischer, P S Mitrou, K Hübner, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Recombinant human granulocyte-macrophage colony-stimulating factor after combined chemotherapy in high-grade non-Hodgkin's lymphoma--a randomised pilot studyL Bergmann, T Karakas, A Knuth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCRJ Brieger, E Weidmann, U Maurer, et al.
Praxis Und Klinik Der Pneumologie|May 1, 1977
[Pulmonary manifestations of collagen diseases and necrotizing angiitis (author's transl)]J Meier-Sydow, M Amthor, P S Mitrou, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Impaired T- and B-cell functions in patients with Hodgkin's disease. Reduced mitogenic responsibility and Il-2 production is not caused by defective CD4+-cellsL Bergmann, P S Mitrou, M Demmer-Dieckmann, et al.
Pageof 11